Treat-and-extend: The way forward?

Professor Ramin Tadayoni discusses the benefits of the treat-and-extend regimen compared to fixed dose and PRN dosing. Although trial data with fixed dosing schedules show maximal visual acuity gains, such a regimen is not a feasible long-term solution.

Posted: 9/29/2015